

Njbio India Pharmaceutical Profile
Key Indicators
- Authorised Capital ₹ 20.00 Cr
- Paid Up Capital ₹ 16.37 Cr
- Company Age 6 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 8.16 Cr
- Revenue Growth 114.92%
- Profit Growth 235.45%
- Ebitda 368.98%
- Net Worth 258.45%
- Total Assets 8.21%
About Njbio India Pharmaceutical
Njbio India Pharmaceutical Private Limited (NIPPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 10 January 2019 (Six years and two months 18 days old ). Its registered office is in Mumbai, Maharashtra, India.
The Corporate was formerly known as Amar Chemistry Private Limited. The Company is engaged in the Travel And Hospitality Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 20.00 Cr and a paid-up capital of Rs 16.37 Cr.
The company has closed loans amounting to ₹8.16 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Njbio India Pharmaceutical Private Limited India is Hetvi Sheth as COMPANY SECRETARY. Nareshkumar Jain and Arpit Pokharna serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U73100MH2019PTC319319
- Company No.
319319
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Jan 2019
- Date of AGM
27 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Njbio India Pharmaceutical?
Executive Team (1)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Hetvi Sheth | Company Secretary | 05-Apr-2023 | Current |
Board Members (2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Nareshkumar Jain ![]() | Director | 10-Jan-2019 | Current |
Arpit Pokharna ![]() | Director | 01-Sep-2023 | Current |
Financial Performance of Njbio India Pharmaceutical.
Njbio India Pharmaceutical Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 114.92% increase. The company also saw a substantial improvement in profitability, with a 235.45% increase in profit. The company's net worth Soared by an impressive increase of 258.45%.


- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Njbio India Pharmaceutical?
In 2023, Njbio India Pharmaceutical had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Charges (Loans)
₹0
₹8.16 Cr
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 8.16 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
20 Aug 2019 | Hdfc Bank Limited | ₹8.16 Cr | Satisfied |
How Many Employees Work at Njbio India Pharmaceutical?
Njbio India Pharmaceutical has a workforce of 38 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Njbio India Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Njbio India Pharmaceutical's trajectory.
Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Njbio India Pharmaceutical
Recent activity within the organization
- Annual General Meeting
Njbio India Pharmaceutical Private Limited last Annual general meeting of members was held on 27 Sep 2024 as per latest MCA records.
- Balance Sheet
Njbio India Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.
- Director Appointment
Arpit Pokharna was appointed as a Director was appointed as a Director on 01 Sep 2023 & has been associated with this company since 1 year 6 months .
- Charges
A charge registered on 20 Aug 2019 via Charge ID 100288656 with Hdfc Bank Limited was fully satisfied on 23 May 2023.
- Director Appointment
Hetvi Alpesh Sheth was appointed as a Company Secretary was appointed as a Company Secretary on 05 Apr 2023 & has been associated with this company since 1 year 11 months .
- Charges
A charge with Hdfc Bank Limited of Rs. 8.16 Cr registered on 20 Aug 2019 with Charge ID 100288656 was modified on 02 Feb 2021.
Frequently asked questions
What is the Incorporation or founding date of Njbio India Pharmaceutical Private Limited?
Njbio India Pharmaceutical Private Limited was incorporated on 10 Jan 2019.
What is authorized share capital and paid-up capital of Njbio India Pharmaceutical Private Limited?
The authorized share capital of Njbio India Pharmaceutical Private Limited is ₹ 20.00 Cr and paid-up capital is ₹ 16.37 Cr.
Who are the current board members & directors of Njbio India Pharmaceutical Private Limited?
Currently 3 directors are associated with Njbio India Pharmaceutical Private Limited.
- Nareshkumar Fulchand Jain
- Arpit Pokharna
- Hetvi Alpesh Sheth
What is the registered address of Njbio India Pharmaceutical Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Njbio India Pharmaceutical Private Limited is G-1 G-1A Ground Floor Ackruti Corporate Park Cts No 586 586/1 Lbs Marg Kanjur Village, Bhandup W India, Mumbai, Maharashtra, 400078.
What is the corporate identification number (CIN) and company number of Njbio India Pharmaceutical Private Limited?
The corporate identification number (CIN) of Njbio India Pharmaceutical Private Limited is U73100MH2019PTC319319 and the company number is 319319 as per Ministry of Corporate Affairs (MCA).
What is the official website of Njbio India Pharmaceutical Private Limited?
The Official website of Njbio India Pharmaceutical Private Limited is https://www.amarchemistry.com
What has been the recent revenue trend for Njbio India Pharmaceutical Private Limited?
According to the financial reports for the fiscal year 2023, the revenue trend for Njbio India Pharmaceutical Private Limited has risen by 114.92%.
How many employees does Njbio India Pharmaceutical Private Limited currently have?
As Per 2023 financial reports, 38 employees are currently employed by Njbio India Pharmaceutical Private Limited.
What change has been observed in the net worth of Njbio India Pharmaceutical Private Limited, and by what percentage?
The financial reports for the fiscal year 2023 indicates that The net worth of Njbio India Pharmaceutical Private Limited has experienced an upsurge of 258.45%.
When was the last Balance Sheet of Njbio India Pharmaceutical Private Limited filed with the ROC?
The most recent Balance Sheet for Njbio India Pharmaceutical Private Limited was filed with the ROC on 31 Mar 2024.
People also Viewed
- Vishal ShahManaging Director
MS
Mansi ShahDirector